This report contains market size and forecasts of Cold Pain Therapy in China, including the following market information:
China Cold Pain Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Cold Pain Therapy companies in 2020 (%)
The global Cold Pain Therapy market size is expected to growth from US$ 1456.6 million in 2020 to US$ 1798 million by 2027; it is expected to grow at a CAGR of 2.6% during 2021-2027.
The China Cold Pain Therapy market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Cold Pain Therapy Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Cold Pain Therapy Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
China Cold Pain Therapy Market Segment Percentages,

By Type

, 2020 (%)
OTC Products
Prescription Products

China Cold Pain Therapy Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
China Cold Pain Therapy Market Segment Percentages,

By Application

, 2020 (%)
Musculoskeletal Disorders
Sports Medicine
Post-operative Therapy
Post-trauma Therapy

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cold Pain Therapy revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Cold Pain Therapy revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Beiersdorf
Breg
Custom Ice
DJO Finance
Hisamitsu Pharmaceutical
Johnson & Johnson
Medline Industries
Ossur
Performance Health
Pfizer
Sanofi
Rohto Pharmaceutical
Romsons Group of Industries
Unexo Life Sciences
3M